38 Publications (Page 1 of 2)
2020
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib vs. Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma: Results from the SARC024 Study.RF, Riedel⋅Riedel, Richard F⋅RF, Riedel⋅KV, Ballman⋅KV, Ballman⋅Ballman, Karla V⋅Attia, Steven⋅Y, Lu⋅Y, Lu⋅Loggers, Elizabeth T⋅S, Attia⋅S, Attia⋅ET, Loggers⋅Ganjoo, Kristen N⋅ET, Loggers⋅KN, Ganjoo⋅KN, Ganjoo⋅Livingston, Michael B⋅MB, Livingston⋅MB, Livingston⋅Chow, Warren⋅Wright, Jennifer⋅W, Chow⋅W, Chow⋅Ward, John H⋅J, Wright⋅J, Wright⋅Rushing, Daniel⋅JH, Ward⋅JH, Ward⋅D, Rushing⋅D, Rushing⋅Okuno, Scott H⋅SH, Okuno⋅SH, Okuno⋅Reed, Damon R⋅DR, Reed⋅DR, Reed⋅Liebner, David A⋅Keedy, Vicki L⋅DA, Liebner⋅DA, Liebner⋅RG, Maki⋅RG, Maki⋅Mascarenhas, Leo⋅Davis, Lara E⋅Ryan, Christopher⋅Reinke, Denise K and Maki, Robert GThe oncologist, July 23, 2020.
| Journal Article
Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC‐3G3) to patients with advanced soft tissue sarcomaVillalobos, Victor M⋅Mo, Gary⋅Agulnik, Mark⋅Pollack, Seth M⋅Rushing, Daniel A⋅Singh, Arun⋅Van Tine, Brian A⋅McNaughton, Rhian⋅Decker, Rodney L⋅Zhang, Wei⋅Shahir, Ashwin and Cronier, Damien MCancer Medicine, vol. 9, (no. 3), pp. 893, February 2020.
| Journal Article
2019
Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcomaPatel, Shreyaskumar⋅Patel, Shreyaskumar⋅Patel, Shreyaskumar⋅Patel, Shreyaskumar⋅Patel, Shreyaskumar⋅Patel, Shreyaskumar⋅von Mehren, Margaret⋅von Mehren, Margaret⋅Reed, Damon R⋅Reed, Damon R⋅Reed, Damon R⋅Reed, Damon R⋅Reed, Damon R⋅Reed, Damon R⋅Kaiser, Pamela⋅Kaiser, Pamela⋅Kaiser, Pamela⋅Kaiser, Pamela⋅Kaiser, Pamela⋅Kaiser, Pamela⋅Charlson, John⋅Charlson, John⋅Charlson, John⋅Charlson, John⋅Charlson, John⋅Charlson, John⋅Ryan, Christopher W⋅Ryan, Christopher W⋅Ryan, Christopher W⋅Ryan, Christopher W⋅Ryan, Christopher W⋅Ryan, Christopher W⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Livingston, Michael⋅Livingston, Michael⋅Livingston, Michael⋅Livingston, Michael⋅Livingston, Michael⋅Livingston, Michael⋅Singh, Arun⋅Singh, Arun⋅Singh, Arun⋅Singh, Arun⋅Singh, Arun⋅Singh, Arun⋅Seth, Rahul⋅Seth, Rahul⋅Seth, Rahul⋅Seth, Rahul⋅Seth, Rahul⋅Seth, Rahul⋅Forscher, Charles⋅Forscher, Charles⋅Forscher, Charles⋅Forscher, Charles⋅Forscher, Charles⋅Forscher, Charles⋅D'Amato, Gina⋅D'Amato, Gina⋅D'Amato, Gina⋅D'Amato, Gina⋅D'Amato, Gina⋅D'Amato, Gina⋅Chawla, Sant P⋅Chawla, Sant P⋅Chawla, Sant P⋅Chawla, Sant P⋅Chawla, Sant P⋅Chawla, Sant P⋅McCarthy, Sharon⋅McCarthy, Sharon⋅McCarthy, Sharon⋅McCarthy, Sharon⋅McCarthy, Sharon⋅McCarthy, Sharon⋅Wang, George⋅Wang, George⋅Wang, George⋅Wang, George⋅Wang, George⋅Wang, George⋅Parekh, Trilok⋅Parekh, Trilok⋅Parekh, Trilok⋅Parekh, Trilok⋅Parekh, Trilok⋅Parekh, Trilok⋅Knoblauch, Roland⋅Knoblauch, Roland⋅Knoblauch, Roland⋅Knoblauch, Roland⋅Knoblauch, Roland⋅Knoblauch, Roland⋅Hensley, Martee L⋅Hensley, Martee L⋅Hensley, Martee L⋅Hensley, Martee L⋅Hensley, Martee L⋅Hensley, Martee L⋅Maki, Robert G⋅Maki, Robert G⋅Maki, Robert G⋅Maki, Robert G⋅Maki, Robert G⋅Maki, Robert G⋅Demetri, George D⋅Demetri, George D⋅Demetri, George D⋅Demetri, George D⋅Demetri, George D and Demetri, George DCancer, vol. 125, (no. 15), pp. 2620, August 1, 2019.
| Journal Article
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic OsteosarcomaDavis, Lara E⋅Davis, Lara E⋅Bolejack, Vanessa⋅Bolejack, Vanessa⋅Ryan, Christopher W⋅Ryan, Christopher W⋅Ganjoo, Kristen N⋅Ganjoo, Kristen N⋅Loggers, Elizabeth T⋅Loggers, Elizabeth T⋅Chawla, Sant⋅Chawla, Sant⋅Agulnik, Mark⋅Agulnik, Mark⋅Livingston, Michael B⋅Livingston, Michael B⋅Reed, Damon⋅Reed, Damon⋅Keedy, Vicky⋅Keedy, Vicky⋅Rushing, Daniel⋅Rushing, Daniel⋅Okuno, Scott⋅Okuno, Scott⋅Reinke, Denise K⋅Reinke, Denise K⋅Riedel, Richard F⋅Riedel, Richard F⋅Attia, Steven⋅Attia, Steven⋅Mascarenhas, Leo⋅Mascarenhas, Leo⋅Maki, Robert G and Maki, Robert GJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 37, (no. 16), pp. 1431, 2019-06-01.
| Journal Article
2018
A randomized, double-blind, placebo-controlled, phase II study of regorafenib vs placebo in advanced/metastatic, treatment-refractory liposarcoma: results from the SARC024 studyRiedel, Richard F⋅Riedel, Richard F⋅Ballman, Karla V⋅Ballman, Karla V⋅Lu, Yao⋅Lu, Yao⋅Attia, Steven⋅Attia, Steven⋅Loggers, Elizabeth Trice⋅Loggers, Elizabeth Trice⋅Ganjoo, Kristen N⋅Ganjoo, Kristen N⋅Livingston, Michael B⋅Livingston, Michael B⋅Chow, Warren Allen⋅Chow, Warren Allen⋅Wright, Jennifer A⋅Wright, Jennifer A⋅Ward, John Harris⋅Ward, John Harris⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Okuno, Scott H⋅Okuno, Scott H⋅Reed, Damon R⋅Reed, Damon R⋅Liebner, David A⋅Liebner, David A⋅Keedy, Vicki Leigh⋅Keedy, Vicki Leigh⋅Mascarenhas, Leo⋅Mascarenhas, Leo⋅Davis, Lara Emily⋅Davis, Lara Emily⋅Ryan, Christopher W⋅Ryan, Christopher W⋅Reinke, Denise K⋅Reinke, Denise K⋅Maki, Robert G and Maki, Robert GJournal of Clinical Oncology, vol. 36, (no. 15_suppl), pp. 11505, 2018-05-20.
| Journal Article
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to ImatinibSchuetze, Scott M⋅Schuetze, Scott M⋅Schuetze, Scott M⋅Bolejack, Vanessa⋅Bolejack, Vanessa⋅Bolejack, Vanessa⋅Thomas, Dafydd G⋅Thomas, Dafydd G⋅Thomas, Dafydd G⋅von Mehren, Margaret⋅von Mehren, Margaret⋅von Mehren, Margaret⋅Patel, Shreyaskumar⋅Patel, Shreyaskumar⋅Patel, Shreyaskumar⋅Samuels, Brian⋅Samuels, Brian⋅Samuels, Brian⋅Choy, Edwin⋅Choy, Edwin⋅Choy, Edwin⋅D'Amato, Gina⋅D’Amato, Gina⋅D’Amato, Gina⋅Staddon, Arthur P⋅Staddon, Arthur P⋅Staddon, Arthur P⋅Ganjoo, Kristen N⋅Ganjoo, Kristen N⋅Ganjoo, Kristen N⋅Chow, Warren A⋅Chow, Warren A⋅Chow, Warren A⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Forscher, Charles A⋅Forscher, Charles A⋅Forscher, Charles A⋅Priebat, Dennis A⋅Priebat, Dennis A⋅Priebat, Dennis A⋅Loeb, David M⋅Loeb, David M⋅Loeb, David M⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Okuno, Scott⋅Okuno, Scott⋅Okuno, Scott⋅Reinke, Denise K⋅Reinke, Denise K⋅Reinke, Denise K⋅Baker, Laurence H⋅Baker, Laurence H and Baker, Laurence HJAMA Oncology, vol. 4, (no. 6), pp. 820, 2018-06-01.
| Journal Article
2017
A phase II trial of regorafenib (REGO) in patients (pts) with advanced Ewing sarcoma and related tumors (EWS) of soft tissue and bone: SARC024 trial resultsAttia, Steven⋅Bolejack, Vanessa⋅Ganjoo, Kristen N⋅George, Suzanne⋅Agulnik, Mark⋅Rushing, Daniel A⋅Loggers, Elizabeth Trice⋅Livingston, Michael B⋅Wright, Jennifer A⋅Chawla, Sant P⋅Okuno, Scott H⋅Reinke, Denise K⋅Riedel, Richard F⋅Davis, Lara Emily⋅Ryan, Christopher W and Maki, Robert GJournal of Clinical Oncology, vol. 35, (no. 15_suppl), pp. 11005, 2017-05-20.
| Journal Article
Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trialHensley, Martee L⋅Hensley, Martee L⋅Hensley, Martee L⋅Patel, Shreyaskumar R⋅Patel, Shreyaskumar R⋅Patel, Shreyaskumar R⋅von Mehren, Margaret⋅von Mehren, Margaret⋅von Mehren, Margaret⋅Ganjoo, Kristen⋅Ganjoo, Kristen⋅Ganjoo, Kristen⋅Jones, Robin L⋅Jones, Robin L⋅Jones, Robin L⋅Staddon, Arthur⋅Staddon, Arthur⋅Staddon, Arthur⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Milhem, Mohammed⋅Milhem, Mohammed⋅Milhem, Mohammed⋅Monk, Bradley⋅Monk, Bradley⋅Monk, Bradley⋅Wang, George⋅Wang, George⋅Wang, George⋅McCarthy, Sharon⋅McCarthy, Sharon⋅McCarthy, Sharon⋅Knoblauch, Roland E⋅Knoblauch, Roland E⋅Knoblauch, Roland E⋅Parekh, Trilok V⋅Parekh, Trilok V⋅Parekh, Trilok V⋅Maki, Robert G⋅Maki, Robert G⋅Maki, Robert G⋅Demetri, George D⋅Demetri, George D and Demetri, George DGynecologic Oncology, vol. 146, (no. 3), pp. 537, September 2017.
| Journal Article
SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath TumorsHigham, Christine⋅Higham, Christine S⋅Higham, Christine S⋅Higham, Christine S⋅Higham, Christine S⋅Higham, Christine⋅Steinberg, Seth M⋅Steinberg, Seth⋅Steinberg, Seth⋅Steinberg, Seth M⋅Steinberg, Seth M⋅Steinberg, Seth M⋅Dombi, Eva⋅Dombi, Eva⋅Dombi, Eva⋅Dombi, Eva⋅Dombi, Eva⋅Dombi, Eva⋅Perry, Arie⋅Perry, Arie⋅Perry, Arie⋅Perry, Arie⋅Perry, Arie⋅Perry, Arie⋅Helman, Lee⋅Helman, Lee J⋅Helman, Lee⋅Helman, Lee J⋅Helman, Lee J⋅Helman, Lee J⋅Schuetze, Scott M⋅Schuetze, Scott⋅Schuetze, Scott M⋅Schuetze, Scott⋅Schuetze, Scott M⋅Schuetze, Scott M⋅Ludwig, Joseph A⋅Ludwig, Joseph A⋅Ludwig, Joseph A⋅Ludwig, Joseph⋅Ludwig, Joseph⋅Ludwig, Joseph A⋅Staddon, Arthur⋅Staddon, Arthur⋅Staddon, Arthur⋅Staddon, Arthur⋅Staddon, Arthur⋅Staddon, Arthur⋅Milhem, Mohammed⋅Milhem, Mohammed M⋅Milhem, Mohammed M⋅Milhem, Mohammed⋅Milhem, Mohammed M⋅Milhem, Mohammed M⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Jones, Robin L⋅Jones, Robin⋅Jones, Robin⋅Jones, Robin L⋅Jones, Robin L⋅Jones, Robin L⋅Livingston, Michael⋅Livingston, Michael⋅Livingston, Michael⋅Livingston, Michael⋅Livingston, Michael⋅Livingston, Michael⋅Goldman, Stewart⋅Goldman, Stewart⋅Goldman, Stewart⋅Goldman, Stewart⋅Goldman, Stewart⋅Goldman, Stewart⋅Moertel, Christopher⋅Moertel, Christopher⋅Moertel, Christopher⋅Moertel, Christopher⋅Moertel, Christopher⋅Moertel, Christopher⋅Wagner, Lars⋅Wagner, Lars⋅Wagner, Lars⋅Wagner, Lars⋅Wagner, Lars⋅Wagner, Lars⋅Janhofer, David⋅Janhofer, David⋅Janhofer, David⋅Janhofer, David⋅Janhofer, David⋅Janhofer, David⋅Annunziata, Christina M⋅Annunziata, Christina M⋅Annunziata, Christina⋅Annunziata, Christina⋅Annunziata, Christina M⋅Annunziata, Christina M⋅Reinke, Denise⋅Reinke, Denise⋅Reinke, Denise⋅Reinke, Denise⋅Reinke, Denise⋅Reinke, Denise⋅Long, Lauren⋅Long, Lauren⋅Long, Lauren⋅Long, Lauren⋅Long, Lauren⋅Long, Lauren⋅Viskochil, David⋅Viskochil, David⋅Viskochil, David⋅Viskochil, David⋅Viskochil, David⋅Viskochil, David⋅Baker, Larry⋅Baker, Larry⋅Baker, Larry⋅Baker, Larry⋅Baker, Larry⋅Baker, Larry⋅Widemann, Brigitte⋅Widemann, Brigitte C⋅Widemann, Brigitte C⋅Widemann, Brigitte C⋅Widemann, Brigitte and Widemann, Brigitte CSarcoma, vol. 2017, pp. 8, 20170912.
| Journal Article
2016
Abstract 2258: Digital whole slide quantitative image analysis of TOPO II and P53 in sarcomas evaluating both primary and lung metastatic tumorsStrack, Margaret⋅Strack, Margaret⋅Sandusky, George⋅Sandusky, George⋅Rushing, Daniel and Rushing, DanielCancer Research, vol. 76, (no. 14 Supplement), pp. 2258, 2016-07-15.
| Journal Article
Abstract CT145: A phase I open-label study to evaluate the effect of olaratumab on the pharmacokinetics (PK) of doxorubicin (Dox) in patients with advanced soft tissue sarcoma (STS)Villalobos, Victor⋅Agulnik, Mark⋅Pollack, Seth M⋅Rushing, Daniel A⋅Singh, Arun⋅Van Tine, Brian A⋅Okereke, Chukwuemeka⋅Ng, Wee Teck and Cronier, Damien MCancer Research, vol. 76, (no. 14 Supplement), pp. CT145, 2016-07-15.
| Journal Article
Clinical benefit of a precision medicine based approach for guiding treatment of refractory cancers.Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Kiel, Patrick J⋅Kiel, Patrick J⋅Kiel, Patrick J⋅Kiel, Patrick J⋅Kiel, Patrick J⋅Nance, Stacy M⋅Nance, Stacy M⋅Nance, Stacy M⋅Nance, Stacy M⋅Nance, Stacy M⋅Niland, Erin E⋅Niland, Erin E⋅Niland, Erin E⋅Niland, Erin E⋅Niland, Erin E⋅Parsley, Megan E⋅Parsley, Megan E⋅Parsley, Megan E⋅Parsley, Megan E⋅Parsley, Megan E⋅Ferguson, Meagan E⋅Ferguson, Meagan E⋅Ferguson, Meagan E⋅Ferguson, Meagan E⋅Ferguson, Meagan E⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Jiang, Guanglong⋅Ammakkanavar, Natraj R⋅Ammakkanavar, Natraj R⋅Ammakkanavar, Natraj R⋅Ammakkanavar, Natraj R⋅Ammakkanavar, Natraj R⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Cheng, Liang⋅Nassiri, Mehdi⋅Nassiri, Mehdi⋅Nassiri, Mehdi⋅Nassiri, Mehdi⋅Nassiri, Mehdi⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Davidson, Darrell D⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Loehrer, Patrick J⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Pili, Roberto⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Hanna, Nasser⋅Callaghan, J Thomas⋅Callaghan, J Thomas⋅Callaghan, J Thomas⋅Callaghan, J Thomas⋅Callaghan, J Thomas⋅Skaar, Todd C⋅Skaar, Todd C⋅Skaar, Todd C⋅Skaar, Todd C⋅Skaar, Todd C⋅Helft, Paul R⋅Helft, Paul R⋅Helft, Paul R⋅Helft, Paul R⋅Helft, Paul R⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅Shahda, Safi⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅O'Neil, Bert H⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P and Schneider, Bryan POncotarget, July 15, 2016.
| Journal Article
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.Schuetze, Scott M⋅Schuetze, Scott M⋅Schuetze, Scott M⋅Bolejack, Vanessa⋅Bolejack, Vanessa⋅Bolejack, Vanessa⋅Choy, Edwin⋅Choy, Edwin⋅Choy, Edwin⋅Ganjoo, Kristen N⋅Ganjoo, Kristen N⋅Ganjoo, Kristen N⋅Staddon, Arthur P⋅Staddon, Arthur P⋅Staddon, Arthur P⋅Chow, Warren A⋅Chow, Warren A⋅Chow, Warren A⋅Tawbi, Hussein A⋅Tawbi, Hussein A⋅Tawbi, Hussein A⋅Samuels, Brian L⋅Samuels, Brian L⋅Samuels, Brian L⋅Patel, Shreyaskumar R⋅Patel, Shreyaskumar R⋅Patel, Shreyaskumar R⋅Mehren, Margaret⋅von Mehren, Margaret⋅Mehren, Margaret⋅D'Amato, Gina⋅D'Amato, Gina⋅D'Amato, Gina⋅Leu, Kirsten M⋅Leu, Kirsten M⋅Leu, Kirsten M⋅Loeb, David M⋅Loeb, David M⋅Loeb, David M⋅Forscher, Charles A⋅Forscher, Charles A⋅Forscher, Charles A⋅Milhem, Mohammed M⋅Milhem, Mohammed M⋅Milhem, Mohammed M⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Lucas, David R⋅Lucas, David R⋅Lucas, David R⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Reinke, Denise K⋅Reinke, Denise K⋅Reinke, Denise K⋅Baker, Laurence H⋅Baker, Laurence H and Baker, Laurence HCancer, October 3, 2016.
| Journal Article
Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcomaSchuetze, Scott⋅Schuetze, Scott⋅Schuetze, Scott⋅Schuetze, Scott⋅Wathen, J.⋅Wathen, J.⋅Wathen, J.⋅Wathen, J.⋅Lucas, David⋅Lucas, David⋅Lucas, David⋅Lucas, David⋅Choy, Edwin⋅Choy, Edwin⋅Choy, Edwin⋅Choy, Edwin⋅Samuels, Brian⋅Samuels, Brian⋅Samuels, Brian⋅Samuels, Brian⋅Staddon, Arthur⋅Staddon, Arthur⋅Staddon, Arthur⋅Staddon, Arthur⋅Ganjoo, Kristen⋅Ganjoo, Kristen⋅Ganjoo, Kristen⋅Ganjoo, Kristen⋅Mehren, Margaret⋅Mehren, Margaret⋅Mehren, Margaret⋅Mehren, Margaret⋅Chow, Warren⋅Chow, Warren⋅Chow, Warren⋅Chow, Warren⋅Loeb, David⋅Loeb, David⋅Loeb, David⋅Loeb, David⋅Tawbi, Hussein⋅Tawbi, Hussein⋅Tawbi, Hussein⋅Tawbi, Hussein⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Rushing, Daniel⋅Patel, Shreyaskumar⋅Patel, Shreyaskumar⋅Patel, Shreyaskumar⋅Patel, Shreyaskumar⋅Thomas, Dafydd⋅Thomas, Dafydd⋅Thomas, Dafydd⋅Thomas, Dafydd⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Reinke, Denise⋅Reinke, Denise⋅Reinke, Denise⋅Reinke, Denise⋅Baker, Laurence⋅Baker, Laurence⋅Baker, Laurence and Baker, LaurenceCancer, vol. 122, (no. 6), pp. 868, 20160315.
| Journal Article
SARC009: Phase 2 study of dasatinib in patients with previously treated, high‐grade, advanced sarcomaSchuetze, Scott M⋅Schuetze, Scott M⋅Schuetze, Scott M⋅Schuetze, Scott M⋅Wathen, J. Kyle⋅Wathen, J. Kyle⋅Wathen, J. Kyle⋅Wathen, J. Kyle⋅Lucas, David R⋅Lucas, David R⋅Lucas, David R⋅Lucas, David R⋅Choy, Edwin⋅Choy, Edwin⋅Choy, Edwin⋅Choy, Edwin⋅Samuels, Brian L⋅Samuels, Brian L⋅Samuels, Brian L⋅Samuels, Brian L⋅Staddon, Arthur P⋅Staddon, Arthur P⋅Staddon, Arthur P⋅Staddon, Arthur P⋅Ganjoo, Kristen N⋅Ganjoo, Kristen N⋅Ganjoo, Kristen N⋅Ganjoo, Kristen N⋅von Mehren, Margaret⋅von Mehren, Margaret⋅von Mehren, Margaret⋅von Mehren, Margaret⋅Chow, Warren A⋅Chow, Warren A⋅Chow, Warren A⋅Chow, Warren A⋅Loeb, David M⋅Loeb, David M⋅Loeb, David M⋅Loeb, David M⋅Tawbi, Hussein A⋅Tawbi, Hussein A⋅Tawbi, Hussein A⋅Tawbi, Hussein A⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Patel, Shreyaskumar R⋅Patel, Shreyaskumar R⋅Patel, Shreyaskumar R⋅Patel, Shreyaskumar R⋅Thomas, Dafydd G⋅Thomas, Dafydd G⋅Thomas, Dafydd G⋅Thomas, Dafydd G⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Chugh, Rashmi⋅Reinke, Denise K⋅Reinke, Denise K⋅Reinke, Denise K⋅Reinke, Denise K⋅Baker, Laurence H⋅Baker, Laurence H⋅Baker, Laurence H and Baker, Laurence HCancer, vol. 122, (no. 6), pp. 874, March 15, 2016.
| Journal Article
2013
Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.Demetri, George D⋅Chawla, Sant P⋅Ray-Coquard, Isabelle⋅Cesne, Axel⋅Le Cesne, Axel⋅Staddon, Arthur P⋅Milhem, Mohammed M⋅Penel, Nicolas⋅Riedel, Richard⋅Bui-Nguyen, Binh⋅Cranmer, Lee⋅Reichardt, Peter⋅Bompas, Emmanuelle⋅Alcindor, Thierry⋅Rushing, Daniel⋅Song, Yang⋅Lee, Ruey-Min⋅Ebbinghaus, Scot⋅Eid, Joseph E⋅Loewy, John W⋅Haluska, Frank G⋅Dodion, Pierre F and Blay, Jean-YvesJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 31, (no. 19), pp. 2485-92, 2013/Jul/1.
| Journal Article
SARC006: Phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 (NF1)-associated high-grade malignant peripheral nerve sheath tumors (MPNSTs)Widemann, Brigitte C⋅Reinke, Denise K⋅Helman, Lee J⋅Ludwig, Joseph A⋅Schuetze, Scott⋅Staddon, Arthur P⋅Milhem, Mohammed M⋅Rushing, Daniel A⋅Moertel, Christopher L⋅Goldman, Stewart⋅Livingston, Michael B⋅Wagner, Lars M⋅Rodler, Eve T⋅Dombi, Eva⋅Perry, Arie⋅Annunziata, Christina M⋅Long, Lauren⋅Viskochil, David⋅Steinberg, Seth M and Baker, Laurence HJournal of Clinical Oncology, vol. 31, (no. 15_suppl), pp. 10522, 2013-05-20.
| Journal Article
2012
Phase III, placebo-controlled trial (SUCCEED) evaluating ridaforolimus as maintenance therapy in advanced sarcoma patients following clinical benefit from prior standard cytotoxic chemotherapy: Long-term (≥ 24 months) overall survival resultsBlay, Jean-Yves⋅Chawla, Sant P⋅Ray-Coquard, Isabelle⋅Cesne, Axel Le⋅Staddon, Arthur P⋅Milhem, Mohammed M⋅Penel, Nicolas⋅Riedel, Richard F⋅Bui Nguyen, Binh⋅Cranmer, Lee D⋅Reichardt, Peter⋅Bompas, Emmanuelle⋅Alcindor, Thierry⋅Rushing, Daniel A⋅Song, Yang⋅Ebbinghaus, Scot⋅Haluska, Frank G⋅Dodion, Pierre F and Demetri, George DJournal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 10010, 2012-05-20.
| Journal Article
Substitution of cisplatin for etoposide in 2 of 3 induction cycles of CAV/IE with subsequent irinotecan and vincristine for relapse in adults with Ewing sarcoma (ES) and primitive neuroectodermal tumor (PNET)Rushing, Daniel A⋅Ezewuiro, Obiageli⋅Staehler, Sandra S⋅Potter, Kristin⋅Rojas, Luis and Wagner, Stephanie GlacyJournal of Clinical Oncology, vol. 30, (no. 15_suppl), pp. 9571, 2012-05-20.
| Journal Article
2011
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.Ganjoo, Kristen⋅Cranmer, Lee⋅Butrynski, James E⋅Rushing, Daniel⋅Adkins, Douglas R⋅Okuno, Scott H⋅Lorente, Gustavo⋅Kroll, Stew⋅Langmuir, Virginia K and Chawla, Sant POncology, vol. 80, (no. 1-2), pp. 50-6, 2011.
| Journal Article
2007
Topiramate in the Treatment of Neuropathic Pain in Patients with CancerBendaly, Edmond A⋅Jordan, Carol A⋅Staehler, Sandra S and Rushing, Daniel ASupportive Cancer Therapy, vol. 4, (no. 4), pp. 246, September 2007.
| Journal Article
2006
Gastrointestinal stromal tumors: CT and MRI findingsSandrasegaran, K.⋅Rajesh, A.⋅Rushing, D.A.⋅Rydberg, J.⋅Akisik, F.M. and Henley, J.D.Clinical Imaging, vol. 30, (no. 1), 2006.
| Journal Article
Phase II study of intravenous TZT‐1027 in patients with advanced or metastatic soft‐tissue sarcomas with prior exposure to anthracycline‐based chemotherapyPatel, Shreyaskumar⋅Patel, Shreyaskumar⋅Keohan, Mary Louise⋅Keohan, Mary Louise⋅Saif, M. Wasif⋅Saif, M. Wasif⋅Rushing, Daniel⋅Rushing, Daniel⋅Baez, Luis⋅Baez, Luis⋅Feit, Kevie⋅Feit, Kevie⋅DeJager, Robert⋅DeJager, Robert⋅Anderson, Sibyl and Anderson, SibylCancer, vol. 107, (no. 12), pp. 2887, 15 December 2006.
| Journal Article
2005
Gastrointestinal stromal tumors: clinical, radiologic, and pathologic features.Sandrasegaran, Kumaresan⋅Sandrasegaran, Kumaresan⋅Rajesh, Arumugam⋅Rajesh, Arumugam⋅Rydberg, Jonas⋅Rydberg, Jonas⋅Rushing, Daniel A⋅Rushing, Daniel A⋅Akisik, Fatih M⋅Akisik, Fatih M⋅Henley, John D and Henley, John DAJR. American journal of roentgenology, vol. 184, (no. 3), pp. 803-11, 2005/Mar.
| Journal Article
Gastrointestinal stromal tumors: CT and MRI findings.Sandrasegaran, Kumaresan⋅Sandrasegaran, Kumaresan⋅Rajesh, Arumugam⋅Rajesh, Arumugam⋅Rushing, Daniel⋅Rushing, Daniel A⋅Rydberg, Jonas⋅Rydberg, Jonas⋅Akisik, Fatih M⋅Akisik, Fatih⋅Henley, John and Henley, John DEuropean radiology, vol. 15, (no. 7), pp. 1407-14, 2005/Jul.
| Journal Article